Philip Brown

Philip M. Brown is Dermavant’s Chief Medical Officer. He has over 25 years of experience leading clinical development programs. Prior to joining Dermavant in January 2019, Dr. Brown served as head of global pharmaceutical development at Galderma. He also has served in other clinical development leadership roles in both public and private biotechnology companies, including Senior Vice President of Clinical Development at Lexicon Pharmaceuticals, a publicly-traded biopharmaceutical company.